Stroke Update 2009: 급성기 뇌졸중 치료
Stroke Update 2009: Acute Stroke Therapy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Stroke is a common cause of death in Korea. The concept of acute intervention has been emphasized in ischemic stroke. Partic-ularly, technical advances and the enhanced availability of imaging technic have permitted new challenges of thrombolysis based on the selection of ‘tissue at risk’ of brain after acute ischemic stroke. This article present a review of clinical trials for acute treatment of stroke introduced in 2008. (Korean J Stroke 2009;11:56-61)
Abstract
Stroke is a common cause of death in Korea. The concept of acute intervention has been emphasized in ischemic stroke. Partic-ularly, technical advances and the enhanced availability of imaging technic have permitted new challenges of thrombolysis based on the selection of ‘tissue at risk’ of brain after acute ischemic stroke. This article present a review of clinical trials for acute treatment of stroke introduced in 2008. (Korean J Stroke 2009;11:56-61)
참고문헌 (17)
- Tomsick TA, "Intravenous thrombolysis for acute ischemic stroke", J vasc Interv Radio, 15, pp.67~76 (2004)
- Wahlgren N, "Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study", Lancet, 372, pp.1303~1309 (2008)
- Wahlgren N, "Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study", Lancet, 369, pp.275~282 (2007)
- Hacke W, "Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke", N Engl J Med, 359, pp.1317~1329 (2008)
- Barber PA, "Prediction of stroke outcome with echoplanar perfusion-and diffusion-weighted MRI", Neurology, 51, pp.418~426 (1998)
- Köhrmann M, "Stroke-MRI: extending the time-window: recent trials and clinical practice", Int J Stroke, 2, pp.53~54 (2007)
- Hacke W, "The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase", Stroke, 36, pp.66~73 (2005)
- Hacke W, "Intravenous desmoteplase in patients with acute ischaemic stroke se-lected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebocontrolled study", Lancet Neurol, 8, pp.141~150 (2009)
- Davis SM, "Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Throm bolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial", Lancet Neurol, 7, pp.299~309 (2008)
- Albers GW, "Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study", Ann Neurol, 60, pp.508~517 (2006)
- Kane I, "Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systemic review of the evidence of date", J neurol Neurosurg Psychiatry, 78, pp.485~491 (2007)
- Gobin YP, "MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia", Stroke, 35, pp.2848~2854 (2004)
- Smith WS, "Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial", Stroke, 39, pp.1205~1212 (2008)
- Bose A, "Penumbra Phase 1 Stroke Trial Investigators. The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism", AJNR Am J Neuroradiol, 29, pp.1409~1413 (2008)
- Mayer SA, "Europe", AustralAsia NovoSeven ICH Trial Investigators. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage, 2005, pp.36, 74~79
- Mayer SA, "Efficacy and Safety of Recombinant activated factor VII for Acute Intracerebral Hemorrhage", N Engl J Med, 358, pp.2127~2137 (2008)
- Anderson CS, "Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial", Lancet Neurol, 7, pp.391~399 (2008)